Literature DB >> 19000752

Traditional Chinese herb Dihuang Yinzi (DY) plays neuroprotective and anti-dementia role in rats of ischemic brain injury.

Rong Hu1, Chang-lin Yin, Nan Wu, Gao-yu Cui, Hui Meng, Xi-gui Wu, Hai-shui Luo, Tian Gang, Shengli Hu, Jiantao Shi, Jiang-kai Lin, Hua Feng.   

Abstract

AIM OF THE STUDY: Traditional Chinese herb Dihuang Yinzi (DY) is well known to treat neurological diseases by traditional Chinese medical practitioners. This study is to elucidate its neuroprotective and anti-dementia role in ischemic brain injury.
MATERIALS AND METHODS: The effects of DY on the pathohistological changes, lactate dehydrogenase (LDH) release, Morris water maze task, expression of synaptophysin (SYP) and extracellular signal-regulated protein kinase (ERK) of hippocampi of rats with ischemic brain injury were investigated.
RESULTS: This study showed that DY not only significantly decreased the number of TUNEL-positive cells but also reduced the LDH release of hippocampus of model rat. Morris water maze test showed that the ability of learning and memory of rats dramatically impaired after ischemic brain injury. However, DY ameliorated the impairment of learning and memory of ischemic rats. Furthermore, western blotting and immunohistochemical data showed that the expression of extracellular regulated protein and synaptophysin, which correlates with synaptic formation and function, decreased after ischemic insult. However, DY inhibited the reduction of ERK an SYP expression in a dose-dependent way.
CONCLUSION: These results suggest that DY possesses neuroprotective and anti-dementia properties, at least in part, by preventing the loss of neural cells and synapses in ischemic brain injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19000752     DOI: 10.1016/j.jep.2008.09.035

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  7 in total

1.  Yizhi Xingnao prescription improves the cognitive function of patients after a transient ischemic attack.

Authors:  Donglin Jiang; Xing Chu; Lingling Hu; Shengyang Jiang; Feng Hu; Junming Sun; Chengwan Li
Journal:  Neural Regen Res       Date:  2012-02-25       Impact factor: 5.135

2.  Dihuang Yinzi, a Classical Chinese Herbal Prescription, for Amyotrophic Lateral Sclerosis: A 12-Year Follow-up Case Report.

Authors:  Hui Qiu; Ji-Huang Li; Su-Bing Yin; Jiang-Qiong Ke; Chang-Lin Qiu; Guo-Qing Zheng
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

3.  Dihuang-Yinzi Alleviates Cognition Deficits via Targeting Energy-Related Metabolism in an Alzheimer Mouse Model as Demonstrated by Integration of Metabolomics and Network Pharmacology.

Authors:  Guanghui Han; Weizhe Zhen; Yuan Dai; Hongni Yu; Dongyue Li; Tao Ma
Journal:  Front Aging Neurosci       Date:  2022-04-01       Impact factor: 5.702

Review 4.  Neuroprotective effects of Morinda officinalis How.: Anti-inflammatory and antioxidant roles in Alzheimer's disease.

Authors:  Yi Zhang; Meng Zhang
Journal:  Front Aging Neurosci       Date:  2022-09-08       Impact factor: 5.702

5.  Iron (FeII) chelation, ferric reducing antioxidant power, and immune modulating potential of Arisaema jacquemontii (Himalayan Cobra Lily).

Authors:  Rasleen Sudan; Madhulika Bhagat; Sahil Gupta; Jasvinder Singh; Anupurna Koul
Journal:  Biomed Res Int       Date:  2014-05-06       Impact factor: 3.411

Review 6.  Ameliorating effects of traditional Chinese medicine preparation, Chinese materia medica and active compounds on ischemia/reperfusion-induced cerebral microcirculatory disturbances and neuron damage.

Authors:  Kai Sun; Jingyu Fan; Jingyan Han
Journal:  Acta Pharm Sin B       Date:  2015-01-24       Impact factor: 11.413

Review 7.  Mitochondrial MPTP: A Novel Target of Ethnomedicine for Stroke Treatment by Apoptosis Inhibition.

Authors:  Yangxin Li; Jiayi Sun; Ruixia Wu; Jinrong Bai; Ya Hou; Yong Zeng; Yi Zhang; Xiaobo Wang; Zhang Wang; Xianli Meng
Journal:  Front Pharmacol       Date:  2020-03-25       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.